Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/41322
Título: | Anticancer properties of the abietane diterpene 6,7-dehydroroyleanone obtained by optimized extraction | Autores/as: | Garcia, Catarina Oliveira Silva, Catarina Monteiro, Carlos M. Nicolai, Marisa Viana, Ana Andrade, Joana M. Barasoain, Isabel Stankovic, Tijana Quintana, Jose Hernandez Gonzalez, Inmaculada González Robaina, Ignacio J. Estevez, Francisco Díaz-Lanza, Ana María Reis, Catarina P. Afonso, Carlos A. M. Pešić, Milica Rijo, Patricia |
Clasificación UNESCO: | 32 Ciencias médicas 3209 Farmacología 320101 Oncología |
Palabras clave: | Cytotoxicity Derivatives Resistance Quinones Therapy, et al. |
Fecha de publicación: | 2018 | Publicación seriada: | Future Medicinal Chemistry | Resumen: | Aim: 6,7-dehydroroyleanone (DHR) is a cytotoxic abietane present in the essential oil of Plectranthus madagascariensis. Methods/results: Different extraction parameters were tested, and its extraction optimization was accomplished with a Clevenger apparatus-based hydrodistillation. After isolation, its effect on microtubules, P-glycoprotein and caspases was assessed on several cell lines and the compound was coupled with hybrid nanoparticles. The results show that DHR does not interfere with microtubule formation, but evades the resistance mechanisms of P-glycoprotein. Strong activation of caspases-3 and -9 indicates that DHR is able to induce apoptosis by triggering the intrinsic cell death pathway. Moreover, the assembly of DHR with hybrid nanoparticles was able to potentiate the effect of DHR in cancer cells. Conclusion: DHR seems to be a promising starting material with anticancer properties to further be explored. | URI: | http://hdl.handle.net/10553/41322 | ISSN: | 1756-8919 | DOI: | 10.4155/fmc-2017-0239 | Fuente: | Future Medicinal Chemistry[ISSN 1756-8919],v. 10 (10), p. 1177-1189 |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.